Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background: Diabetes mellitus (DM) is a prevalent disease among elderly population. As the disease progresses, insulin may become necessary. The use of pens application seems to be more practical. However, the influence of this method on glycemic control needs to be defined in elderly people. Methods: Randomized clinical trial comparing pens and syringes for insulin application among patients with type 2 DM over 60 years old and Glycated Hemoglobin > 8.5% at baseline. The follow-up was 24 weeks, with monthly medical visits to adjust the treatment. All patients received insulin NPH and, if necessary, insulin Regular. We assessed glycemic control, adherence to treatment, hypoglycemia occurrence, need for adjustment in treatment and impact on quality of life, Results: We included 121 patients with mean age of 65.75 years. Sixty-one were randomized for pen group (PG) and 60 patients for syringe group (SG). At baseline, mean HbA1c was 10.34 ± 1.66% and 9.90 ± 1.25% (p = 0.103) in PG and SG respectively. Mean HbA1c was 8.39 ± 1.28% in PG and 8.85 ± 1.74% in SG (p = 0.101) at 24 weeks. However, there was a more significant reduction in PG (− 1.94 ± 1.93% in PG and − 1.04 ± 1.46% in SG, p < 0.05) during follow-up. We found no difference in treatment adherence rates, hypoglycemia, greater need for insulin doses or oral medication, and progression to basal-bolus insulin scheme. We also found no difference in the impact of the disease on quality of life between groups. Conclusion: Although we did not find any difference in the impact on quality of life, frequency of hypoglycemia or adherence, the PG showed a reduction in HbA1c higher in 24 weeks of follow-up. Clinical trial registration: NCT02517242
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Injecting insulin with a syringe or pen (136-147) is the insulin delivery method used by most people with diabetes (142,148), although inhaled insulin is also available.”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Introduction: Standards of Medical Care in Diabetes—2019
(2019) · Diabetes Care · doi:10.2337/dc19-sint01 · Cited by 356
Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes
Donnelly, L. A., Morris, A. D., Evans, J. M. M., & for the DARTS/MEMO collaboration (2007) · QJM · doi:10.1093/qjmed/hcm031 · Cited by 230
Farmer, A. J., Perera, R., Ward, A., Heneghan, C., Oke, J., Barnett, A. H., Davidson, M. B., Guerci, B., Coates, V., Schwedes, U., et al. (2012) · BMJ · doi:10.1136/bmj.e486 · Cited by 156
Peyrot, M., Barnett, A. H., Meneghini, L. F., & Schumm‐Draeger, P. ‐. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01636.x · Cited by 143
Pawaskar, M. D., Camacho, F., Anderson, R. T., Cobden, D., Joshi, A. V., & Balkrishnan, R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.007 · Cited by 119 · cited 1×
“With advancing age, the number of episodes seems to increase, regardless of glycemic control [12].”
BackgroundGross, C. C., Scain, S. F., Scheffel, R. S., Gross, J. L., & Hutz, C. S. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.022 · Cited by 116 · cited 2×
“We evaluated Quality of Life through questionnaires [10, 11] applied on the first and last visits.”
BackgroundMethodTradução para o português e validação do instrumento Diabetes Quality of Life Measure (DQOL-Brasil)
Correr, C. J., Pontarolo, R., Melchiors, A. C., Rossignoli, P., Fernández-Llimós, F., & Radominski, R. B. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000300012 · Cited by 65 · cited 2×
“We evaluated Quality of Life through questionnaires [10, 11] applied on the first and last visits.”
BackgroundMethodLasalvia, P., Barahona-Correa, J. E., Romero-Alvernia, D. M., Gil-Tamayo, S., Castañeda-Cardona, C., Bayona, J. G., Triana, J. J., Laserna, A. F., Mejía-Torres, M., Restrepo-Jimenez, P., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633721 · Cited by 63
Cited by
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 280
Metadata
- Authors
- Machry, R. V., Cipriani, G. F., Pedroso, H. U., Nunes, R. R., Pires, T. L. S., Ferreira, R., Vescovi, B., de Moura, G. P., & Rodrigues, T. C.
- Affiliations
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade Federal de Santa Maria (BR)
- Corresponding author
- Machry, Rafael Vaz
- ORCID
- Machry, Rafael Vaz
- Venue
- Diabetology & Metabolic Syndrome
- Published
- 2021-06-12
- Volume
- 13
- Issue
- 1
- Pages
- 64-64
- ISSN
- 1758-5996 (ISSN-L)
- PMC
- PMC8196455
- OpenAlex
- W3166144534
- Cited by
- 13
- References
- 18
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 4 · 2022: 1 · 2021: 1
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetology & Metabolic Syndrome (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Funders
- CNPq (#4012.68/2013.6)
- Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- insulin pens, insulin syringes, insulin delivery method, type 2 diabetes, elderly patients, glycemic control, HbA1c, NPH insulin, hypoglycemia, medication adherence, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial. https://app.cochat.ai/papers/10.1186/s13098-021-00675-y
- The paper
- Machry, R. V., Cipriani, G. F., Pedroso, H. U., Nunes, R. R., Pires, T. L. S., Ferreira, R., Vescovi, B., de Moura, G. P., & Rodrigues, T. C. (2021). Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-021-00675-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.